Ideal outcome | PML3 | PMI | PMD | |||
---|---|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
Age ≥ 65 | 0.275 (0.104–0.729) | 0.009 | 0.194 (0.073–0.515) | 0.001 | 0.213 (0.085–0.531) | 0.001 |
CCI ≥ 1 | 0.290 (0.096–0.874) | 0.028 | 0.308 (0.105–0.904) | 0.032 | 0.371 (0.134–1.022) | 0.055 |
Sepsis | 0.019 (0.004–0.094) |  < 0.001 | 0.021 (0.004–0.099) |  < 0.001 | 0.024 (0.005–0.109) |  < 0.001 |
Sarcopenia | 0.160 (0.058–0.436) |  < 0.001 | 0.176 (0.065–0.480) | 0.001 | 0.514 (0.204–1.292) | 0.157 |
Ideal outcome | TPG | PBSA | ||
---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Age ≥ 65 | 0.233 (0.091–0.595) | 0.002 | 0.182 (0.067–0.493) | 0.001 |
CCI ≥ 1 | 0.339 (0.119–0.967) | 0.043 | 0.343 (0.116–1.011) | 0.052 |
Sepsis | 0.024 (0.005–0.110) |  < 0.001 | 0.020 (0.004–0.100) |  < 0.001 |
Sarcopenia | 0.264 (0.102–0.681) | 0.006 | 0.159 (0.059–0.427) |  < 0.001 |
Mortality at 30-days | PML3 | PMI | PMD | |||
---|---|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
Age ≥ 65 | 2.386 (0.886–6.422) | 0.085 | 3.334 (1.265–8.790) | 0.015 | 3.186 (1.263–8.038) | 0.014 |
CCI ≥ 1 | 3.691 (1.180–11.547) | 0.025 | 3.395 (1.116–10.326) | 0.031 | 2.866 (0.996–8.247) | 0.051 |
Sepsis | 78.036 (9.667–629.942) |  < 0.001 | 70.958 (8.964–561.702) |  < 0.001 | 64.746 (8.396–499.279) |  < 0.001 |
Sarcopenia | 6.326 (2.287–17.499) |  < 0.001 | 4.983 (1.842–13.477) | 0.002 | 2.256 (0.885–5.748) | 0.088 |
Mortality at 30-days | TPG | PBSA | ||
---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Age ≥ 65 | 2.827 (1.081–7.391) | 0.034 | 3.538 (1.317–9.509) | 0.012 |
CCI ≥ 1 | 3.213 (1.069–9.662) | 0.038 | 3.111 (1.018–9.506) | 0.046 |
Sepsis | 66.086 (8.437–517.681) |  < 0.001 | 71.272 (8.880–572.032) |  < 0.001 |
Sarcopenia | 4.571 (1.732–12.065) | 0.002 | 5.712 (2.133–15.295) | 0.001 |